期刊文献+

应用含CpG基序的寡核苷酸增强乙型肝炎病毒基因疫苗诱导的细胞免疫应答 被引量:6

CpG oligodeoxyribonucleotide potently enhances cellular immune responses induced by hepatitis B virus gene vaccines
原文传递
导出
摘要 目的 探讨人工合成的含CpG基序的寡核苷酸 (ODN)作为佐剂对乙型肝炎病毒(HBV)基因疫苗诱导小鼠产生细胞免疫应答的影响。方法 构建编码HBV表面抗原蛋白S的重组真核表达质粒 pCR3.1 S作为HBV基因疫苗 ,人工合成含CpG基序 (motif)的硫代磷酸寡核苷酸作为佐剂 ,以Balb/c小鼠作为实验动物进行免疫接种 ;采用3 H TdR法、51Cr 4h释放法等分别检测免疫小鼠的淋巴细胞增殖和杀伤功能。结果 与空载体对照组相比较 ,HBV基因疫苗诱发Balb/c小鼠产生较好的HBV特异的淋巴细胞增殖及杀伤效应 (P <0 .0 5 ) ;应用CpGODN组与未应用组相比较 ,免疫小鼠产生更强的HBV特异性细胞免疫应答 (P <0 .0 5 )。 Objective To investigate the effects of CpG oligodeoxyribonucleotide (ODN) as adjuvants on cellular immune responses in mice immunized with hepatitis B virus (HBV) gene vaccines. Methods Recombinant eukaryotic expression plasmids of pCR3.1 S encoding S protein of HBV were constructed as gene vaccines. Phosphorothioate oligodeoxynucleotides containing one CpG motif were synthesized as adjuvants. Then Balb/c mice were inoculated so that the immune responses to HBV could be studied. Lymphocyte proliferation reactions and cytotoxic T lymphocyte activities were detected through 3H TdR incorporation and 4 hour 51 Cr release assays. Results Compared with plasmid vectors of pCR3.1, HBV gene vaccines could induce strong lymphocyte proliferation reactions and cytotoxic T lymphocyte activities in immunized mice ( P <0.05). Immunized mice with CpG ODN showed higher specific cellular responses to HBV than those without CpG ODN ( P <0.05). Conclusion CpG ODN can act as adjuvants to enhence cellular immune responses in mice immunized with HBV gene vaccines.
出处 《中华传染病杂志》 CSCD 北大核心 2000年第2期80-83,共4页 Chinese Journal of Infectious Diseases
基金 国家自然科学基金! ( 3 9770 665 )
关键词 乙型肝炎 HBV CPG基序 ODN 基因疫苗 免疫应答 CpG oligodeoxyribonucleotide Hepatitis B virus Gene vaccine Cellular immunity response
  • 相关文献

参考文献8

二级参考文献180

共引文献192

同被引文献81

  • 1张政,王福生.CpG-ODN免疫学功能及其应用研究[J].免疫学杂志,2003,19(S1):122-125. 被引量:11
  • 2Wen Jie Dai,Hong Chi Jiang Second Department of General Surgery, the First Clinical School, Harbin Medical University, Harbin 150001, Heilongjiang Province, China.Advances in gene therapy of liver cirrhosis: a review[J].World Journal of Gastroenterology,2001,7(1):1-8. 被引量:34
  • 3Huang F,Zhao GZ,Li Y.HCV genotypes in hepatitis C patients and their clinical significances[J].World Journal of Gastroenterology,1999,5(6):547-549. 被引量:23
  • 4曹文娥 穆文广.HBV围产期感染和宫内阻断的临床研究[J].解放军医学杂志,1992,17:58-58.
  • 5Weeratna RD, McCluskie MJ, Comanita L, et al. Optimization strategies for DNA Vaccines. Inter Virol,2000,43:218-226.
  • 6Thermet A, Christine R, Zoulim F, et al. Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine, 2003,21:659-662.
  • 7Prince AM, Whalen R, Brotman B, et al. Successful nucleic acid based immunication of newborn chimpanzees against hepatitis B virus. Vaccine,1997,15:916.
  • 8Tacket CO, Roy MJ, Widera G. Phage 1 safety and immune respons e studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine,1999,17:2826-2829.
  • 9Michael ML, Goldbeck C, Pertile T, et al. Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future. Vaccine,2001,19:2395-2399.
  • 10Swain WE, Heydenburg-Fuller D, Wu MS, et al. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev Biol(Basel),2000,104:115-119.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部